Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation
Synonyms |
|
||||||||||||||||
Cerner Name |
|||||||||||||||||
Clinical Info |
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody baseline for future comparisons in monitoring a patient's clinical course and response to immunomodulatory treatment |
||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||
Specimen Types |
Blood |
||||||||||||||||
Specimen Volume |
3 mL serum ( 2 mL min) |
||||||||||||||||
Container |
Red Top Tube |
||||||||||||||||
Collection Instructions |
Container/Tube: Red top tube or Gold Top Tube |
||||||||||||||||
Transport Instructions |
|||||||||||||||||
Specimen Stability |
72 Hours Room Temperature |
||||||||||||||||
Methodology |
ARBI, CCPQ, MUSK: Radioimmunoassay (RIA)ACMFS: Flow Cytometry |
||||||||||||||||
Days Performed |
|||||||||||||||||
Performing Laboratories |
Mayo Medical Laboratories |
||||||||||||||||
CPT |
86041,86596 |
||||||||||||||||
PDM |
5910940 |
||||||||||||||||
Results |
|
||||||||||||||||
Result InterpretationMG Lambert-Eaton Interpretation, S Interpretation NA |
|||||||||||||||||
Forms |
|
||||||||||||||||

